Becton, Dickinson and Company Stock Xetra

Equities

BOX

US0758871091

Medical Equipment, Supplies & Distribution

Market Closed - Xetra 11:35:31 2024-07-11 am EDT 5-day change 1st Jan Change
207.5 EUR -0.43% Intraday chart for Becton, Dickinson and Company -2.17% -4.82%
Sales 2024 * 20.25B 18.63B Sales 2025 * 21.47B 19.76B Capitalization 65.01B 59.83B
Net income 2024 * 2.09B 1.93B Net income 2025 * 2.48B 2.28B EV / Sales 2024 * 3.86 x
Net Debt 2024 * 13.13B 12.08B Net Debt 2025 * 10.81B 9.95B EV / Sales 2025 * 3.53 x
P/E ratio 2024 *
31.4 x
P/E ratio 2025 *
27.8 x
Employees 73,000
Yield 2024 *
1.68%
Yield 2025 *
1.72%
Free-Float 77.74%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.43%
1 week-2.17%
Current month-5.12%
1 month-6.32%
3 months-7.37%
6 months-7.37%
Current year-4.82%
More quotes
1 week
207.50
Extreme 207.5
211.50
1 month
207.50
Extreme 207.5
223.50
Current year
206.90
Extreme 206.9
232.60
1 year
206.90
Extreme 206.9
263.50
3 years
202.30
Extreme 202.3
265.45
5 years
194.80
Extreme 194.8
265.45
10 years
194.80
Extreme 194.8
265.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 50 08-12-31
Director of Finance/CFO 52 21-09-05
Chief Tech/Sci/R&D Officer 48 18-12-31
Members of the board TitleAgeSince
Director/Board Member 73 02-09-23
Director/Board Member 73 13-01-28
Director/Board Member 69 10-07-25
More insiders
Date Price Change Volume
24-07-11 207.5 -0.43% 20
24-07-09 208.4 -0.24% 45
24-07-08 208.9 -0.62% 330
24-07-05 210.2 -0.24% 95
24-07-04 210.7 -0.66% 7

Delayed Quote Xetra, July 11, 2024 at 11:35 am EDT

More quotes
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
223.9 USD
Average target price
277.8 USD
Spread / Average Target
+24.09%
Consensus